Recombinant Human Anti-CD64 x Human Anti-malaria antigen Bispecific Antibody (scFv-CH1/CL) (BSCC-H303)

Recombinant Anti-CD64 x Anti-malaria antigen Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-CD64 antibody variable domain is fused to CH1 and the other scFv from an anti-malaria antigen antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can retarget NK cells to genus plasmodium. It is designed for the research of Malaria therapy.

Datasheet INQUIRY

Specifications

Targets

CD64 & malaria antigen

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Malaria

Targets

Target 1

CD64

Gene ID

2209

UniProt ID

P12314

Alternative Names

FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI

Target 2

malaria antigen

Alternative Names

malaria antigen; parasitic protozoans

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "CD64 & malaria antigen"

See other bsAb targets related to "CD64"

See other bsAb targets related to "malaria antigen"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD64 x Human Anti-malaria antigen Bispecific Antibody (scFv-CH1/CL) (BSCC-H303). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-CD64 x Human Anti-malaria antigen Bispecific Antibody (scFv-CH1/CL) (CAT#: BSCC-H303)

Specifications

Targets

Customer Reviews and Q&As